Neuromodulation News and Research

RSS
Revance Therapeutics raises $33M in Series E financing

Revance Therapeutics raises $33M in Series E financing

APS to present scientific abstracts at Experimental Biology 2013

APS to present scientific abstracts at Experimental Biology 2013

Ohio State's Wexner Medical Center performs DBS surgery on Alzheimer's patient

Ohio State's Wexner Medical Center performs DBS surgery on Alzheimer's patient

Sacral nerve stimulation helps manage children with chronic incontinence

Sacral nerve stimulation helps manage children with chronic incontinence

Intelligent algorithms for programming deep brain stimulation in Parkinson’s to be developed by Great Lakes NeuroTechnologies

Intelligent algorithms for programming deep brain stimulation in Parkinson’s to be developed by Great Lakes NeuroTechnologies

Festive season can trigger new cases of tinnitus

Festive season can trigger new cases of tinnitus

Boston Scientific’s Precision Spectra Spinal Cord Stimulator System receives CE Mark approval

Boston Scientific’s Precision Spectra Spinal Cord Stimulator System receives CE Mark approval

Advance Study to evaluate safety and benefit of DBS-f for patients with mild Alzheimer's

Advance Study to evaluate safety and benefit of DBS-f for patients with mild Alzheimer's

First U.S. patient treated with deep brain stimulation for Alzheimer's at Johns Hopkins

First U.S. patient treated with deep brain stimulation for Alzheimer's at Johns Hopkins

Long-term hippocampal DBS effectively reduces seizures in experimental models

Long-term hippocampal DBS effectively reduces seizures in experimental models

Neuros Medical honored as most promising startup

Neuros Medical honored as most promising startup

Boston Scientific receives CE MARK approval for Vercise DBS to treat Parkinson's

Boston Scientific receives CE MARK approval for Vercise DBS to treat Parkinson's

Medtronic to acquire Kanghui

Medtronic to acquire Kanghui

Trigeminal Nerve Stimulation: an interview with Dr Leon Ekchian, President and CEO of NeuroSigma

Trigeminal Nerve Stimulation: an interview with Dr Leon Ekchian, President and CEO of NeuroSigma

Sacral neuromodulation cost-effective for fecal incontinence

Sacral neuromodulation cost-effective for fecal incontinence

NeuroSigma's external Trigeminal Nerve Stimulation system awarded CE Certification

NeuroSigma's external Trigeminal Nerve Stimulation system awarded CE Certification

ImThera Medical announces results from targeted hypoglossal neurostimulation study on OSA

ImThera Medical announces results from targeted hypoglossal neurostimulation study on OSA

Deep brain stimulation has important role in treating severe Tourette’s

Deep brain stimulation has important role in treating severe Tourette’s

FDA approves Codman’s MEDSTREAM Programmable Infusion System

FDA approves Codman’s MEDSTREAM Programmable Infusion System

Uroplasty first quarter global sales increase 20% to $5.6 million

Uroplasty first quarter global sales increase 20% to $5.6 million